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ABSTRACT
Transcription activator-like effector (TALE) proteins are important for DNA
binding. They bind to specific nucleotide sequences by the use of two residues in each
repeat allowing them to target specific DNA sequences. Their modular structure makes
TALEs advantageous over other DNA binding proteins such as zinc finger proteins.
Zinc finger proteins (ZFP) use a finger like projection to bind 3-4 subsequence
base pairs while TALE proteins use two amino acid residues in each repeat to bind one
nucleotide. ZFP can use SEER-Lac system for colorimetric detection, while TALE
proteins can use fluorescence labeling with Alexa for detection of binding to DNA.
The TALE proteins simplistic design makes them easily manipulated and
advantageous for genome engineering. They recognize DNA through a tandem array and
an RVD (repeat variable diresidue) loop on the 12th and 13th residue in the amino acid
chain. Upon binding to DNA, TALEs use fluorescence labeling to emit a signal that can
be detected over unbound DNA. This method of targeting DNA is being used for the
detection of pathogens which can lead to rapid point-of-care (POC) diagnostic devices.
In the research presented, TALE protein purification process has been optimized
through techniques that manipulate the cell culture to yield high concentrations of the
protein. The methods use a two-column purification technique with His tag and a maltose
binding protein linked to the protein. The assay for target DNA detection has been
optimized through binding the proteins to the gel surface with interactions strong enough
to resist washing steps. The assay used the Alexa bound fluorescence molecules to prove
protein bound to target DNA complexes with fluorescence spectroscopy.
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INTRODUCTION
DNA Binding Complexes
DNA binding structures and proteins are important for the function and regulation
of DNA. DNA binding proteins can be used to identify, track, and alter the original
function of DNA within cells making their purpose important for the study and regulation
of DNA. DNA binding proteins can interact with DNA through the major and minor
grooves of DNA1. Sequence-specific DNA binding proteins such as zinc finger proteins
(ZFPs) are an efficient way of identifying important DNA sequences within organisms
and provide a wide range of uses2. These proteins bind to specific DNA strands without
denaturing the original DNA. ZFPs and transcription activator-like effectors (TALEs)
proteins bind DNA2,3.
Zinc Finger Proteins
ZFPs are DNA-binding domains with a finger like structure containing two
cysteine and two histidine residues bound a zinc ion4. This structure gives the protein
stabilization while allowing each finger projection to bind to 3-4 corresponding DNA
nucleotide base pairs5. Multiple ZFP domains can be engineered in a tandem array
allowing the recognition of extended DNA sequences2.
SEER LAC System
The Sequence-enabled reassembly system (SEER-Lac) using the enzyme
lactamase for quick assembly is equipped to be paired with ZFPs for quick detection of
target DNA6. The combination of the ZFPs and the lactamase create a visual detection of
binding through the lactamase’s enzymatic assembly through nitrocefin colorimetric
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assay. The SEER-Lac system works by assembling the two ZFPs with two lactamase
enzymatic fragments linked to each ZFP upon a pair of ZFPs binding to their target DNA.
The system works by using the ZFP’s ability to recognize specific DNA nucleotide
sequence. The pair of ZFPs bind the continuous sites in the DNA sequence. Upon binding
to the DNA, the two inactive parts of the lactamase enzyme are adjacent to each other
which allows for assembling to the full-length enzyme, which is then measured through a
colorimetric enzyme assay2. This mechanism is how ZFP’s can be used to identify target
DNA sequences present in pathogens.
TALE
Transcription activator like effectors (TALEs) are a new class of DNA-binding
domains7. TALEs can be a superior method for specific DNA binding due to their
modular structure that increases specificity and is easier to manipulate, which would be
advantageous for biomedical applications8. TALEs consist of multiple repeats and each
repeat consists of 34 amino acids in length with residues 3-11 and 15-333 comprising of
two helixes while the 12th residue stabilizes the RVD (repeat variable diresidue) loop and
the 13th residue specifically recognizes DNA bases8. Figure 1.1 depicts the 12th and 13th
residues of the amino acid sequence that form the RVD loop. The DNA target sequence
of the RVD loop is shown in Figure 1.2 and the binding of the specific amino acids in
TALE to the target DNA sequence is shown in Figure 1.4. The orientation of the amino
acid RVD loop to bound DNA is shown in Figure 1.3.

2

Figure 1.1. TALE linear schematic. Linear amino
acid sequence of TALE depicting the 12th and 13th
residues that make up the binding domain for DNA.

Figure 1.2. DNA target sequence. Target DNA sequence
in stx2 gene encoding a Shiga toxin in E. Coli O157.
Capture protein target sequence in green and detection
protein target sequence in purple.
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Figure 1.3. DNA bound TALE. The 12th and 13th
residue of TALE bound to the target DNA. Proteins
bound with H bonds and van der Waals forces
shown.9
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Figure 1.4. RVD and their respective DNA sequence. The RVD loops of the TALE proteins with the 12th and 13th
amino acid residues bound to their respective nucleotide bases. Green DNA strand is the target DNA of the
capture TALE stx2_236 and the purple DNA strand is the target DNA of the detection TALE stx_255.
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The target DNA sequences of the TALE proteins is shown in Figure 1.4 with the
RVDs of the TALE proteins bound to one specific base pair of DNA. The TALE proteins
were specifically designed to recognize this DNA sequence and could be engineered to
recognize other DNA sequences. This target DNA sequence is unique to Shiga toxin
producing E. coli. The target DNA sequences are recognized by the 12th and 13th residues
of the TALE proteins which is shown above in Figure 1.4. The recognition is made
possible by combining multiple repeats comprised of corresponding RVDs in TALEs in
tandem array9. Multiple repeats are fused to form TALE domains in various length in the
order needed to recognize the target DNA sequence.
The TALEs were originally engineered to consist of a capture and detection probe
that binds to the stx2 gene coding for Shiga toxin in E. coli O157 (foodborne) as shown in
Figure 1.2 and 1.3 above; eventually, the TALEs will target bloodborne pathogens. The
detection probe of TALE was fluorescently labeled with Alexa fluorescence labeling
which allowed the TALE to give an emission when binding of the target DNA
occurred10. The capture probe was immobilized on an acrylamide gel surface on a glass
slide that allowed the capture of the target DNA. The Alexa labeled detection TALE
probe was applied to the bound complex of the capture probe and DNA. The use of
TALEs to detect DNA in a wide range of host organisms has exponential possibilities for
detection of pathogens in the presence of large amounts of non-target DNA7.
Figure 1.5 shows a schematic diagram for TALE array which consist of two
TALE proteins, a capture and a detection probe, that bind to target DNA and emit a
fluorescence detection signal upon binding in less than 5 minutes. This rapid detection
mechanism would be advantageous for rapid detection of specific pathogens such as
4

hepatitis viruses in third world countries that currently lack advance technologies for
DNA sequencing and testing.

Figure 1.5. TALE protein array. The target DNA is detection through labeling of
the detection probe with Alexa fluorescence and the array steps. The capture probe
is added, then target DNA, then detection probe. The final protein complex is
detected with spectroscopy.
The goal of this research is to optimize the purification and immobilization of
TALE proteins on a gel surface to target DNA in the detection array shown in Figure 1.5.
The research took place in two stages: First, the optimization of the purification process
of TALEs through varying culture sizes and temperatures. Second, the optimization of
the immobilization of the proteins and DNA through manipulation of the washing steps
in the array.
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MATERIALS AND METHODS
1. Protein Construction

Agel

Xhol

pMAL-c2X

Figure 2.1. Vector Map for pMAL-c2X. The pMAL-c2x vector map used to clone TALE proteins.

The vector map shown in Figure 2.1 depicts the pMAL-c2X vector used to clone the
TALE proteins. TALE was cloned between Xhol and Agel sites of pMAL-c2X including
the N and C-terminal truncated regions. TALE stx2_236 and 255 were subcloned
between Stul and AatII sites of pMAL-c2X. The vector enables expression of the proteins
through fusion with a maltose binding protease (MBP) and His purification tag. The
proteins were expressed with E. coli BL21 upon induction with 0.1mM Isopropyl β-D-1thiogalactopyranoside (IPTG) at OD=0.6-0.8 overnight at room temperature (18C).
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2. TALE Purification
This purification process occurs in 3 Day increments. On day 1, the cells were
inoculated. 5 mL of Lysogeny Broth (LB) was combined with 5 L of ampicillin and a
colony from the plate of the protein I am purifying. The cells are spun overnight at 37 °C.
On day 2, the inoculated cell culture was combined to make a total of 2 grown L culture
with an additional 95 L of ampicillin. The cells were spun at the same temperature, 37
°C, and 150rpm until they reach an OD value of 0.4. Next, the sample was shaken at 30
°C, if possible, until an OD level of 0.6-0.8 was reached. Once the OD level was reached
the culture was induced with 200 µL of 0.5 M IPTG and spun overnight at 18 °C. Next,
the sample was centrifuged at 10000 rpm for 15 minutes at 4 °C. The supernatant was
discarded, and the pellet was kept for resuspension. The pellet can then be stored at -80
°C or can be continued onto day 3. The final day, the pellet was suspended in 100 mL of
Lysis Wash Buffer (2 mM sodium azide, 500 mM NaCl, 5 mM imidazole, 20 mM Tris
pH 7.9) and collected in 20 mL aliquots. The sample. was then sonicated on ice six times
for ten seconds. The newly lysed cells were spun at 10000 rpm for 40 minutes at 4 °C.
During this time, a column was prepared by adding 3-4 mL of nickel resin into the
column. Next, 20 mL of Lysis Wash Buffer was added and run through gravity filtration,
the resin becomes packed in the column. The sample was then loaded into the column,
washed with 100 mL of Lysis Wash Buffer, 100mL of high-salt buffer (2 mM sodium
azide, 2 mM NaCl, 5 mM imidazole, 20 mM Tris pH 7.9), another 100 mL of Lysis wash
buffer, and then eluded. The protein was eluded in 9 mL of His Elution buffer (2 mM
sodium azide, 500 mM NaCl, 500 mM imidazole, 20 mM Tris pH 7.9) and caught in 9 of
1 mL fractions. Bradford assay was done to determine protein concentration, and the
7

fractions with concentrations of around 0.04 M and above were set aside for an amylose
resin column. A 1 mL packed amylose resin column was packed, equilibrated with 20 mL
of TALE storage buffer (480 mM KCl, 1.6 mM EDTA, 2 mM DTT, 12 mM Tris pH 7.5),
and the selected fractions run through. The protein was eluded with 5mL of TALE
storage buffer + 10 mM maltose in 5 of 1 ml aliquots. Bradford assay was performed to
determine protein concentration and SDS-PAGE Gel was run to check the purity of the
sample.
3. Alexa Labelling
Alexa 488 fluorescence labeling was done on the detection TALE-probe. The
labeling was done using the kit and the steps listed below in the Appendix, Section B.
First, the protein was resuspended in PBS buffer. The protein was added to a 30kD
Vivaspin tube and centrifuged at 4000 rpm for 1 hour. The goal was to run most all of the
volume through the column while leaving the protein bound to the membrane in the
Vivaspin tube. Then, the PBS buffer was added and pipetted over the membrane multiple
times to resuspend the protein. Now that the protein is in PBS buffer, the protein needs to
be concentrated for the Alexa labeling. The protein will remain in the Vivaspin tube and
spun at 4000 rpm in increments of 5 minutes to allow for checking of the concentration.
The protein needs to be at 1 M concentration while have the greatest volume possible to
allow for multiple assays. Next, the protein was ready for conjugation. 1 M solution of
sodium bicarbonate was made by adding 1 mL of deionized water to the provided vial of
sodium bicarbonate (Component B). The solution was mixed via vortex or pipetting. Up
to 100 L of the protein sample can be used at one time, 1 mg/ml concentration in PBS
buffer. 10 µL of 1 M sodium bicarbonate solution and 10 µL of DMSO is added to one
8

vial of Alexa 488 dye (component A) and completely dissolve the contents by vortexing
or magnetic stirring. The concentration of the dye stock solution should be 0.0113 M.
The optimal degree of labeling (DOL) was then determined based on molecular weight of
the protein. The appropriate amount of dye was calculated to be added such that the final
concentration of dye in the protein sample is: Final concentration of dye = protein
concentration x DOL. The dye was added, and the vial wrapped in aluminum foil and
incubated at room temperature for 15 minutes. The proteins were wrapped in aluminum
foil as much as possible. While the sample was incubating, the spin column (component
D) with the resin (component E) was prepared. 800 L of resin slurry (invert resin
several times to resuspend; do not vortex) was pipetted into a spin column and
centrifuged for 1 minute at 10,000 rpm. The column was equilibrated by centrifuging 400
L of the PBS buffer at 10,000 rpm for 1 minute and then again for a total of two times.
After incubating the protein sample at room temperature, the entire sample was pipetted
into the packed column spin tube and centrifuge at 10,000 rpm with the high side of the
resin on the outside for 1 minute to elude the labeled protein. A low and high side of the
resin slurry will occur because of centrifugation.
4. TALE Protein Assay
The assay was composed of a silicon gasket placed in duplicate, one on top of
another, on a glass slide in order to create 4 different places for the different conditions of
the assay to occur. The glass slide is first cleaned by placing it in a 60°C water bath for
five minutes and then run through a plasma cleaner. The slide was then covered with 100
l of a cilia solution (two-part trimethoxysilyl propyl methacrylate; two-part acetic acid;
and two-part methanol) for 5-10 minutes before washing with 1 ml methanol and dried.
9

The slide was cleaned with a plasma cleaner to rid it of any gases and the cilia solution
was used to help adhere the following gel solution to the slide. The two-part silicon
gasket was then applied creating 4 separate places or holes for the gel solution to be
added. 30 l of the gel solution (14 l 30% acrylamide, 81 l TALE buffer, and 5 l VA044 solution) was added to each hole created by the gasket (see Appendix, Section C).
The slide was placed in a water bath at 50°C for 5 minutes. The slide was then washed
with ZBA + 0.1M KCl and then ZBA + 0.1% Tween20 detergent solution by pipetting
into each of the 4 holes of the gasket. 10 l of TALE stx2_236 capture protein was then
added to the desired holes and incubated for 10 minutes to immobilize on the gel. The
same washing steps were repeated before adding DNA to the desired holes. 10 l of
DNA bound to Alexa, 0.5 M and 1M, were added to different gaskets creating 8
different reaction conditions (each gasket had 4 holes with 1 for control, 2 for DNA +
protein, and 1 for protein only). Again, the washing steps are done after the DNA bound
to Alexa was added. The assay was read using a spectrophotometer at 260-500 nm
wavelengths and 30 times per 1 minute with a total of 30 minutes.
The goal of optimization of protein immobilization was tested with the procedure
outlined in Figure 3.1. The capture protein TALE stx2_236 was added to the gel surface
along with Alexa labeled target DNA sequence to allow for binding. The target DNA was
added at two different concentrations, 0.5 and 1 M.
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Figure 3.1. TALE protein array with capture probe. The immolilization of capture probe TALE stx2_236 and
detection of Alexa labeled target DNA on gel surface.
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RESULTS
The goal of the design was to bind the engineered TALE stx2_236 to the specific
target DNA sequence and detect the Alexa bound fluorescence. The capture probe would
be immobilized on a gel slide and subsequently the target sequence would be added. A
washing step would get rid of any unbound molecules before the detection step. The slide
would then be read by fluorescence spectroscopy to detect the level of emission from the
bound TALE and DNA. The goal of this study is to optimize the purification of the
TALE proteins and the binding of the TALE protein on the gel slide.
Optimizing purification was performed by varying the purification steps as far as
amount of culture and the temperature of growth at various parts in the purification
process. The specific aim is to obtain purified proteins above 0.4 M in concentration in
order to bind the detection probe with fluorescence and have both capture and detection
probes bind to the target DNA. SDS-PAGE gel was run to determine if the purified
protein was present with the expected size and check Bradford assay was performed to
determine concentration of the proteins.
In this first experiment, the cells were grown in 300 ml culture at 37C until
OD=0.6-0.8 and then at 20C overnight. The culture volume and temperature used was
different than the final protocol listed in the methods, but no other changes were made.
The rest of the protocol follows the procedure outline in appendix A.

Protein

Fraction 1

Fraction 2

Fraction 3
12

Fraction 4

Fraction 5

Lac A stx
268
Stx 233 lac
B
Stx 268

(M)
0

(M)
0. 0066

(M)
0.0405

(M)
0.0194

(M)
0.0049

0.0091

0.0657

0.0377

0.0599

0.0139

0

0.1509

0.0267

0

0

Figure 4.1. Table results from Lac A stx 268, stx 233 lac B, and stx 268. The table shows the results, in M, from
purification with a low culture volume and high temperatures.

Cultures Grown in 300ml
0.16
0.14
0.12
0.1
0.08
0.06
0.04
0.02
0
Fraction 1 (𝜇M) Fraction 2 (𝜇M) Fraction 3 (𝜇M) Fraction 4 (𝜇M) Fraction 5 (𝜇M)
Lac A stx 268

Stx 233 lac B

Stx 268

Figure 4.2. Graph of results from Lac A stx 268, stx 233 lac B, and stx 268. The graph shows a visual
representation of the results from the purification in Figure 4.1 in M.

In the next experiment, the cells were grown in 1 L culture at 37C until OD=0.4,
then 30C until OD=0.6-0.8, and grown for 3-4 hours at 18C. This indicated the changes
in culture and temperature protocol, but no other changes were made. The rest of the
protocol follows the procedure outline in appendix A.

Protein

Fraction 1
(M)

Fraction 2
(M)

Fraction 3
(M)
13

Fraction 4
(M)

Fraction 5
(M)

Lac A SEB
400
SEB 435
Lac B

0

0.35238

0.50714

0.38095

0.30895

0

0.57808

0.30685

0.02192

0

Figure 4.3. Table results from Lac A SEB 400 and SEB 435 Lac B. The table shows the results, in M, from
purification with increased culture size and lower temperatures after induction with IPTG.

Growth at 1L culture and lower temperature
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
Fraction 1 (𝜇M) Fraction 2 (𝜇M) Fraction 3 (𝜇M) Fraction 4 (𝜇M) Fraction 5 (𝜇M)
Lac A SEB 400

SEB 435 Lac B

Figure 4.4. Graph results from Lac A SEB 400 and SEB 435 Lac B. The graph shows the results from the
purification and the fraction concentrations shown in Figure 4.3.

In the next experiment, the SEB 435 cells were grown in a total of 1L culture but in
4 cultures of 250 mL each. The SEB 400 cells were grown in a total of 2 L culture but in
4 cultures of 500 mL each. The cells were grown at 37C until OD=0.6-0.8, then 18C
for 3-4 hours. This indicated the changes in culture and temperature protocol, but no
other changes were made. The rest of the protocol follows the procedure outline in
appendix A.
Protein
SEB 400
SEB 435

Fraction 1
(M)
0.0184
0.283077

Fraction 2
(M)
0.0748
1.150769

Fraction 3
(M)
0.0626
0.963077

Fraction 4
(M)
0.0751
1.155385

Fraction 5
(M)
0.0386
0.593846

Figure 4.5. Table results from SEB 400 and SEB 435. The table shows the results, in M, from purification with
different culture sizes, 1 L and 2 L, and lower temperature after induction with IPTG.
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Growth in 250mL X 4 cultures
1.4
1.2
1
0.8
0.6
0.4
0.2
0
Fraction 1 (𝜇M) Fraction 2 (𝜇M) Fraction 3 (𝜇M) Fraction 4 (𝜇M) Fraction 5 (𝜇M)
SEB 400

SEB 435

Figure 4.6. Graph results from SEB 400 and SEB 435. The graph shows the results from the purification and the
fraction concentrations shown in Figure 4.5.

In the purification of TALE, the cells were grown at the exact conditions listed in the
protocol in appendix A. The TALE cells were grown in a 1 L culture, at 37C until
OD=0.4, 30C until OD=0.6-0.8, and 18C overnight.

Protei
n
Stx_2
236
Stx_2
255

Fractio
n1
(M)
0.0415
78
0.0449
46

Fractio
n2
(M)
0.0433
3
0.0349
1

Fractio
n3
(M)
0.0337
0
0.0314
2

Fractio
n4
(M)
0.0446
4
0.0453
8

Fraction
5 (M)

Fraction
6 (M)

Fraction
7 (M)

Fraction
8 (M)

0.03501
3
0.03098
2

0.047268

0.02669
8
0.02530
9

0.03063
7
0.02705
5

0.041891

Fractio
n9
(M)
0.0293
2
0.0322
9

Fraction
10 (M)
0.02144
6
0.01876
4

Figure 4.7. Table results from TALE stx_2 236 and TALE stx_2 255. The table shows the results, in M, from purification of the
transcription activator life effectors with the larger culutre size of 1 L and lowered temperatures before and after induction with IPTG.
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TALE purification
0.05
0.045
0.04
0.035
0.03
0.025
0.02
0.015
0.01
0.005
0
Fraction Fraction Fraction Fraction Fraction Fraction Fraction Fraction Fraction Fraction
1 (𝜇M) 2 (𝜇M) 3 (𝜇M) 4 (𝜇M) 5 (𝜇M) 6 (𝜇M) 7 (𝜇M) 8 (𝜇M) 9 (𝜇M) 10 (𝜇M)
Stx2_236

Stx2_255

Figure 4.8. Graph results from TALE stx_2 236 and TALE stx_2 255. The graph shows the results from the
purification and the fraction concentrations shown in Figure 4.7.

The concentration of the proteins obtained in the experiment can be seen in Figure
4.9 below. TALE stx2_236 fraction 2 has the highest concentration at 1.014659 M and
TALE stx2_255 fraction 2 has the highest concentration at 0.381911 M.

TALE stx2_255

1.1
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0

Concentration (M)

Concentration (M)

TALE stx2_236

1

2

3

4

1.1
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
1

5

2

3

4

5

Fraction Number

Fraction Number

Figure 4.9. Concentration of proteins after purification. The concentration in M of TALE stx2_236 and TALE
stx2_255 after the entire purification process.
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160kDa
100kDa
70kDa

Figure 4.10. SDS-PAGE gel TALE stx2_236 and 255. The results of SDS-PAGE gel for the purified proteins
shown in Figure 4.9. TALE stx2_236 is 108 kDa and TALE stx2_255 is 107 kDa respectively.

SDS-PAGE gel shown above in Figure 4.10 was done to determine if the proteins
are present after purification. The gel contains the ladder, TALE stx2_236 before IPTG
induction, TALE stx2_236 after IPTG induction, TALE stx2_236 fraction 2, and TALE
stx2_255 fraction 2. The fractions correlate to the highest concentration proteins eluded
from the column shown above in Figure 4.9. The TALE proteins are around 107 (TALE
stx2_255) and 108 kDa (TALE stx2_226) and show up on the gel around 100 kDa which
is the correct size. The gel bands above indicate the correct proteins were purified and
expression was increased after adding IPTG.
The concentrated protein were then used for the assay to determine if the proteins
would be imobilized on the gel slide. TALE stx2_236 was added to the gel slide, DNA
bound to fluorescence ALEXA was bound, and the slide was washed of any unbound
DNA before detections. The emmision readings from the fluorescence spectroscopy show
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the ALEXA flourscing which is bound to DNA which it bound to the TALE protein
otherwise it would have been washed away. The emission readings are shown below in
table form in Figure 4.11 and graph form in Figure. 4.12.
DNA
concentration
0.5 𝜇M DNA
1.0 𝜇M DNA

Protein + DNA
Protein + DNA DNA
Control
540
857
520
1176
518
17410
502
795

Figure 4.11. Target DNA concentration and fluorescence emission. The results of fluorescence spectroscopy and
the capture probe bound to ALEXA bound DNA.

TALE array
20000
18000

Intensity (REU)

16000
14000
12000
10000

0.5 𝜇M DNA

8000

1.0 𝜇M DNA

6000
4000
2000
0
Protein + DNA

Protein + DNA

DNA

Control

Condition Tested

Figure 4.12. TALE array emission results. The results depicted in Figure 4.2 in graph representation. The results
of fluorescence spectroscopy and the capture probe bound to Alexa labeled DNA.

The results of the assay show immobilization of the capture probe on the gel surface
at 1.0 M DNA as shown in Figure 4.12. TALE stx2_236 capture probe bound Alexa
labeled 1.0 M DNA. The first condition was also protein + TALE stx2_236 bound to the
DNA but does not show emission which indicated the protein was washed away in the
aggressive washing steps before Alexa bound 1.0 M DNA was added. The fluorescence
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intensity shows the protein was immobilized on the gel surface and bound its target DNA
and the bound protein-DNA complex remains on the gel after the washing steps.
DISCUSSION
The purification process proved to be difficult with consistency. Therefore, the
goal of this study was to optimize the TALE purification process for both TALE stx_2
236 and TALE stx_255. The key players for increasing TALE concentration after the
purification process was the temperature during the process and the amount of culture
used to grow the cells.
Reducing the temperature of the proteins during the purification process appeared
to help improve the stability of the proteins and resulted in higher yield. The proteins
were grown at 37C until the cells OD reached 0.4 and then were grown at 30C until
they reached their OD reached 0.6-0.8. After the cells were induced with IPTG, they were
shaken overnight at 18C. The temperature was decreased during column purification.
The lower temperatures were ideal for maintaining the proteins and stabilization during
column purification.
Another factor that appears to improve stabilization/yield of the protein was the
amount of LB the protein was grown in. Initially, the proteins were grown in 300 ml of
LB broth, but it was increased to 1 L. The larger volumes of cell culture drastically
increased the concentration of the proteins. The concentrations, on average, increased
from results in the 0-0.2 M range to 0.4-1 M concentration of TALE proteins.
Besides for optimizing the purification process, we also optimized the
immobilization of the TALE proteins on the gel slide. The results show the bound
complex of protein and DNA (1 M) remained on the slide after the washing steps in
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order for the bound complex to be detected by fluorescence spectroscopy from Alexa
fluorophore. The high emission readings in Figure 4.3 suggest that the protein was
immobilized on the gel slide and subsequently bound the Alexa labeled DNA. The
inconsistent readings with the two different DNA concentrations may suggest that the
washing steps for the array may not be optimized for 0.5 M of target DNA. The next
step is to optimize the washing steps and amount of target DNA before the full assay can
be performed with the capture and detection probes.
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CONCLUSION
This study was carried out to optimize all portions of the process such as
purification, Alexa labeling, and the array on the gel surface. The purification process
was improved through manipulation of temperatures and culture amounts. The Alexa
labeling was performed and found to be successful. The binding of the proteins to the gel
surface was optimized through careful washing steps and following the protocol found in
the appendix. The further optimization of TALE purification TALE array will make it an
advantageous way to bind and detect DNA.
The next step for the TALE array is to optimize the washing steps and label the
TALE stx2_255 detection probe with Alexa. Oligonucleotides are used in this work but
will change to using cell lysate in subsequent research. Then, the work will be expanded
to bacterial pathogen detection by combing the TALE array with a microfluidic module.
The goal is to apply to research to bacterial detection with a TALE array that minimizes
time and false detection. The goal is an array that can quickly assemble TALE protein
upon detection of a bacterial blood borne pathogen.
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APPENDIX: PROTOCOLS
Section A
TALE Purification Protocol
1. Obtain/transform BL-21 cells that express desired TALE protein. Streak onto
LB/amp plates and incubate in 37°C stationary incubator for 12-14 h, or until
colonies form.
2. Touch a single colony with a large pipet tip and release into a culture tube with 5
mL LB + 100 g/mL amp. Repeat for total 10 culture tubes, if a 1L final culture
volume is desired.
3. Place the tubes in a 37°C shaking incubator at 250 rpm for 12-16 hours, or until
solution is turbid.
4. Combine the 10 culture tubes in a flask of 950 mL LB + amp, so final volume is 1
L.
5. Shake the flask at 250 rpm, 37°C for 1-1.5 h, until the OD600 is 0.4.
6. Continue shaking at 30°C until OD600 is 0.6-0.8.
7. Induce protein expression by adding enough 1M IPTG that the culture is 0.1 mM.
In a 1L culture, this amount is 100 L.
8. Shake at room temperature overnight.
9. Pellet cells by centrifugation for 15 min. at 2000g. Store at -80°C.
Cell Lysis and Protein Purification in 4°C Cold Room
1. Thaw cells and resuspend by pipetting 100 mL of Lysis/Wash Buffer. Make 20mL cell aliquots in large Falcon tubes.

2.

3.
4.
5.
6.
7.

Lysis/Wash Buffer
Make 1 L
2 mM sodium azide
0.13 g
500 mM NaCl
29.22 g
5 mM imidazole
0.34 g
20 mM Tris, pH 7.9*
2.42 g
*Use ~1M HCl
Lyse the cells in each tube using a sonicator set for six 10-second cycles at 50%
amplitude with 10 s rest between cycles. Agitate tube while sonicating and keep
on ice.
Pellet unwanted cell debris by 4°C centrifugation at 15,000xg for 40 min.
Transfer protein solution to new Falcon tube by pipetting. Do not disturb debris
pellet.
In a 4°C cold room, prepare a 20-mL column with a 2 mL bed of His-binding
Nickel Resin. Keep large syringes handy for applying air pressure.
Equilibrate the resin by gently flowing a column-volume, or about 20 mL, of
lysis/wash buffer.
Pass the protein solution through the column to capture His-tagged TALEs.
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8. Pass 100 mL of lysis/wash buffer. Aliquoting the 100-mL washes beforehand
helps keep track.
9. Pass 100 mL of high-salt wash buffer.
High-Salt Wash Buffer
2 mM sodium azide
2 M NaCl
5 mM imidazole
20 mM Tris, pH 7.9

Make 500 mL
0.065 g
58.44 g
0.17 g
1.21 g

10. Pass 100 mL of lysis/wash buffer.
11. Elute TALE proteins from resin with 9 mL of His elution buffer. Catch in six 1.5mL Eppendorf tubes, numbered 1-6.
His Elution Buffer
2 mM sodium azide
500 mM NaCl
500 mM imidazole
20 mM Tris, pH 7.9

Make 500 mL
0.0325 g
14.61 g
8.5 g
0.605 g

12. Measure OD280 of each fraction.
For Fractions Containing >0.1 OD280
1. Combine and pass these fractions through a column containing 1 mL amylose
resin.
2. Wash the resin with 20 mL TALE storage buffer.
TALE Storage Buffer
Make at least 100 mL fresh
480 mM KCl
3.58 g
1.6 mM EDTA
0.467 g
2 mM DTT*
0.03 g
12 mM Tris-Cl, pH 7.5
0.145 g
*Good in sol’n up to 2 days
3. Elute the protein from the resin using 5 mL of TALE storage buffer + 10mM
maltose. Catch in ten 0.5-mL aliquots.
For Fractions Containing 1.0-4.0 OD280
1. Dialyze these fractions against 300 mL of TALE storage buffer + 10 mM maltose.
2. Measure OD280.
3. Flash freeze at -80°C in 50-ml aliquots.
Eluted proteins will maintain binding activity for at least 1 week at 4°C.
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Section B
ALEXA 488 Labeling
 Alexa Fluor 488 dye
 1 M Sodium bicarbonate
 Dimethyl Sulfoxide (DMSO)
 10 X PBS buffer
 1 mM ZnCl2
 10 X TBS buffer
Buffer exchange steps:
1. Add protein sample to a 30 kDa Vivaspin 20 column. 1ml fraction with the
highest concentration
2. Centrifuge at 4C 4000 rpm for 1 hour.
3. Discard flow through buffer in the bottom of the column.
4. To the top of the column add 1ml (amount does not matter) PBS + 0.1 mM ZnCl2
5. Pipet the buffer up and down over the membrane (the filter) to suspend protein in
buffer.
6. Transfer the protein, which is now in the correct buffer to an epi tube and store at
4°C. Now the protein is ready to increase its concentration.
Increase Concentration:
1. Add protein sample now in PBS buffer back to the 30 kD Vivaspin 20 column (if
doing all in the same day do not do step #6 in buffer exchange)
2. Centrifuge at 4°C 4000rpm 10-15 minutes
3. Check the concentration of the protein in the top of the column, discard run
through, and continue centrifuging in 5 min. increments until desired
concentration is met. Concentration needs to be around 1mg/ml and the volume
need to be between 20-100 L. The longer you centrifuge the more concentrated
the protein solution becomes but the volume also decrease as there is more flow
through. Need to have a balance.
4. Proceed to protein conjugation steps.
Protein conjugation steps: (components refer to Alexa labeling kit)
1. Prepare a 1 M solution of sodium bicarbonate by adding 1 mL of deionized water
(dH2O) to the provided vial of sodium bicarbonate (Component B). Vortex or
pipet up and down until fully dissolved. The bicarbonate solution, which will
have a pH ~9.0, can be stored at 4°C for up to two weeks.
2. Add 10 µL of 1 M sodium bicarbonate solution to 100 L of protein sample.
(The amount of 1M sodium bicarbonate should be 1/10 the amount of protein;
i.e. if you have 80uL of protein add 8uL of 1M sodium bicarbonate).
3. Prepare dye; Add 10 µL of DMSO to one vial of Alexa 488 dye (component A)
and completely dissolve the contents by pipetting. The concentration of the dye
stock solution is 0.0113 M. If DMSO is not available autoclaved deionized water
can be used. (The dye is hydrolyzed in water so using DMSO allows the dye to
be active longer). Should be prepared immediately before use and all leftover
discarded.
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4. Calculate an appropriate volume of dye to be added using the following
equation:
𝑢𝑔 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑖𝑛 𝑦𝑜𝑢𝑟 𝑣𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑠𝑎𝑚𝑝𝑙𝑒
(
) (1000)(𝑚𝑜𝑙𝑎𝑟 𝑟𝑎𝑡𝑖𝑜)
𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑀𝑊
= 𝑢𝐿 𝐷𝑦𝑒
11.3

Use the chart to find the molar ratio and choose the MW in kDA closest to your value.
Do not calculate average in between 2 values. Use the closest value.
5. Add the appropriate amount of dye to the sample and mix by pipetting. (The
sample should be shielded from light by covering with aluminum foil from here
forward.)
6. Allow the reaction to incubate at room temp for 15 minutes. If protein
concentration was lower than 1mg/ml then incubation can be extended up to 30
minutes.
7. While the sample is incubating, prepare the spin column (component D) with the
resin (component E).
8. Pipet 800 l of resin slurry (invert resin several times to resuspend; do not
vortex) into a spin column and centrifuge for 1 minute at 10,000 rpm
9. Equilibrate the resin by soaking the beads with approximately 400ul of
appropriate buffer (the buffer that the protein sample in in.)
10. Centrifuge at 10,000 rpm for 1 minute
11. Repeat steps 9 and 10
12. Pipet the whole volume for the reacted protein sample into the high side of the
resin beads (if fixed angle rotor) then centrifuge at 10,000 rpm, with the high
side of the resin on the outside of the centrifuge, for 1 min to elute labeled
proteins. (Unreacted dye is kept in the resin by size-exclusion chromatography).
Degree of labeling determination:
1. Use a spectrophotometer (such as the Nanodrop in Biotech) to measure protein
absorbance at 280 nm and 495 nm. (495 nm is the peak absorbance of the Alexa
label).
2. To obtain the concentration of protein in molarity use the following equation
𝑚𝑔
[(𝐴𝑏𝑠280 − 0.11(𝐴𝑏𝑠495 )] 𝑋 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟
𝑃𝑟𝑜𝑡𝑒𝑖𝑛 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 ( ) =
𝑚𝑔
𝑚𝐿
𝐴𝑏𝑠280 𝑜𝑓 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑎𝑡 1 𝑚𝐿
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𝑚𝑔
𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑎𝑡𝑖𝑜𝑛 ( 𝑚𝐿 )

𝑃𝑟𝑜𝑡𝑒𝑖𝑛 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (𝑀) =

𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑤𝑒𝑖𝑔ℎ𝑡 (𝐷𝑎)
𝑚𝑜𝑙 𝑑𝑦𝑒
𝐴𝑏𝑠280 𝑋 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟
𝐷𝑂𝐿 =
=
𝑚𝑜𝑙 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 71000 𝑋 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (𝑀)
71,000 is the molar extinction coefficient of the 488 dye.
3. If the 𝐴𝑏𝑠280 protein is too low to measure accurately, you can estimate the
%yield and then use the following equation to calculate the concentration.
𝑚𝑔
𝑚𝑎𝑠𝑠(𝑚𝑔)𝑠𝑡𝑎𝑟𝑡𝑖𝑛𝑔 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑋 5𝑦𝑖𝑒𝑙𝑑
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 ( 𝑚𝐿 ) 𝑙𝑎𝑏𝑒𝑙𝑒𝑑 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 =
𝑣𝑜𝑙𝑢𝑚𝑒(𝑚𝐿)𝑟𝑒𝑐𝑜𝑣𝑒𝑟𝑒𝑑
Section C
TALE Assay
Turn on the water bath to 60°C
Wash the slide
Run the slide through the plasma cleaner
Make the cilia: 2-part trimethoxysilyl propyl methacrylate; 2-part acetic acid;
and 2-part methanol
Take slide out of the plasma cleaner keeping the slide upright
Pipet 100 l cilia mixture onto slide all over and wait 5-10 min.
Partially cover petri dish while waiting
Wash slide with 1ml methanol and dry
Prepare the gasket
Make the gel:
14 l 30% AA
81 l TALE buffer
5 l VA-solution
Add the double layer gasket making sure to line up with well plate
Add 30 l gel solution into each hole of the gasket
Put in 50°C water bath for 5mins.
Wash with ZBA + 0.1 M KCl solution
Wash with ZBA + 0.1% Tween20 detergent
Add 10 l TALE_stx2 236; wait 10 min.; do not add to blank
Add 10 l DNA bound to Alexa to desired holes of gasket, wait 10 minutes
Wash the plate with KCl and tweed solution
Cover with aluminum foil
Plate reader at 260-500 and 30 times for 1 min and record results
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